Marshall Wace’s Bioceres Crop Solutions BIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-702,478
Closed -$309K 3180
2026
Q1
$309K Buy
702,478
+107,068
+18% +$81.3K ﹤0.01% 2644
2025
Q4
$780K Buy
595,410
+382,744
+180% +$613K ﹤0.01% 2054
2025
Q3
$300K Buy
+212,666
New +$648K ﹤0.01% 2431
2022
Q4
Sell
-44,419
Closed -$579K 2941
2022
Q3
$579K Buy
44,419
+13,271
+43% +$163K ﹤0.01% 2659
2022
Q2
$427K Buy
31,148
+8,088
+35% +$107K ﹤0.01% 2871
2022
Q1
$315K Buy
23,060
+14,306
+163% +$189K ﹤0.01% 2951
2021
Q4
$125K Buy
+8,754
New +$121K ﹤0.01% 3326

Other funds holding BIOX

Marshall Wace's BIOX Position: Q2 2026 in Review

Marshall Wace sold out of Bioceres Crop Solutions (BIOX) in Q2 2026, closing a stake of 702,478 shares — an estimated $309K sold.

Marshall Wace first reported a position in BIOX in Q4 2021 and held it in 7 quarters. The position peaked at $780K in Q4 2025. 28 funds tracked by Wall St. Rank hold BIOX as of Q2 2026.

  • Marshall Wace reported no remaining Bioceres Crop Solutions position as of Q2 2026 after selling out during the quarter.
  • Marshall Wace sold 702,478 Bioceres Crop Solutions shares in Q2 2026, an estimated $309K.
  • Marshall Wace first reported a position in Bioceres Crop Solutions in Q4 2021 and held it in 7 quarters.
  • Marshall Wace's Bioceres Crop Solutions position peaked at $780K in Q4 2025.
  • 28 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.